Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	78.66	76.68	108.91	77.83	63.56	9.25
Cash & Short-Term Investments	78.66	76.68	108.91	77.83	63.56	9.25
Cash Growth	-5.20%	-29.60%	39.93%	22.45%	586.84%	-32.32%
Prepaid Expenses	0.86	1.59	1.64	1.48	1.32	0.79
Restricted Cash	-	-	0.4	0.39	0.05	0.05
Other Current Assets	-	-	-	0.05	-	-
Total Current Assets	79.52	78.26	110.94	79.75	64.93	10.09
Property, Plant & Equipment	2.27	2.87	2.95	0.64	1.03	1.14
Other Long-Term Assets	0.32	0.31	0.3	-	0.44	0.44
Total Assets	82.11	81.45	114.19	80.39	66.4	11.67
Accounts Payable	7.2	7.95	10.13	5.54	4.34	4.6
Short-Term Debt	-	-	-	-	-	0.38
Current Portion of Leases	0.56	0.54	0.5	0.31	0.43	0.37
Current Unearned Revenue	-	-	-	1	-	-
Total Current Liabilities	7.76	8.49	10.63	6.84	4.77	5.34
Long-Term Leases	1.15	1.57	2.08	0	0.31	0.68
Long-Term Unearned Revenue	35	35	35	-	-	-
Total Liabilities	43.91	45.07	47.71	6.84	5.08	6.03
Common Stock	0.03	0.03	0.03	0.02	0.02	0.01
Additional Paid-In Capital	407.35	373.93	355.22	329.27	292.28	214.4
Retained Earnings	-369.17	-337.58	-288.77	-255.75	-230.97	-208.76
Shareholders' Equity	38.21	36.38	66.48	73.55	61.32	5.64
Total Liabilities & Equity	82.11	81.45	114.19	80.39	66.4	11.67
Total Debt	1.71	2.11	2.58	0.31	0.74	1.43
Net Cash (Debt)	76.95	74.56	106.33	77.52	62.82	7.83
Net Cash Growth	-4.73%	-29.87%	37.17%	23.39%	702.73%	-41.64%
Net Cash Per Share	2.64	2.80	4.40	3.77	5.18	1.57
Filing Date Shares Outstanding	31.2	29.4	25.73	22.14	19.25	10.11
Total Common Shares Outstanding	31.2	27.63	25.67	22.14	17.53	5.49
Working Capital	71.77	69.77	100.31	72.91	60.16	4.74
Book Value Per Share	1.22	1.32	2.59	3.32	3.50	1.03
Tangible Book Value	38.21	36.38	66.48	73.55	61.32	5.64
Tangible Book Value Per Share	1.22	1.32	2.59	3.32	3.50	1.03
Machinery	-	1.24	1.09	0.68	0.6	0.35

Source: S&P Capital IQ. Standard template. Financial Sources.